Experts are still trying to identify these specific mutations and why EBV infection seems to cause them. EBV may also play a role in the development of other health conditions, including autoimmune disorders and schizophrenia. EBV has long been thought to be linked to autoimmune disorders, such as lupus. Experts believe that EBV may cause changes in the way some genes are expressed.
This altered gene expression could increase your risk of developing an autoimmune disorder. One recent study found a potential link between EBV and an increased risk of developing lupus, an autoimmune condition. Still, more research is needed to fully understand the potential link between EBV and autoimmune conditions. A recent study looked at the rates of EBV infection in more people both with and without schizophrenia. The researchers also found that participants with genetic risk factors for schizophrenia as well as elevated antibodies were over eight times more likely to have schizophrenia than the control group.
Further research is needed to study any possible link between EBV infection and schizophrenia. It starts out as a typical EBV infection. But they believe genetic factors or mutations in EBV-infected cells may play a role. EBV infection is very common and is spread by coming into contact with infected bodily fluids. If a teenager or adult is infected, they may experience symptoms like fatigue, swollen lymph nodes, and fever.
In very rare cases, EBV can cause a chronic infection, which can be fatal if left untreated. EBV has also been linked with a variety of conditions, including cancers and autoimmune disorders. Is it possible to contract EBV more than once? And does that mean you can get mono…. There are several types of viral disease, depending on the underlying virus. Bacterial and viral infections are often transmitted in similar ways, but symptoms and treatment methods may vary depending on the cause of your….
Frontiers in oncology. Characterization of the variability of Epstein-Barr virus genes in nasopharyngeal biopsies: potential predictors for carcinoma progression. PloS one. Epstein Barr virus volume 2: one herpes virus: many diseases. Frequent presence of subtype A virus in Epstein-Barr virus-associated malignancies.
Griffiths P. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma. Journal of medical virology. Sequence variation in the Epstein—Barr virus latent membrane protein 1.
Journal of General Virology. The Epstein-Barr virus latent membrane protein-1 LMP1 bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies. Systematic reviews. World journal of surgical oncology. Kieff E. Epstein-Barr virus and its replication. Fields virology. Rowe DT. Epstein-Barr virus immortalization and latency. Front Biosci. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer.
The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. Journal of Biological Chemistry. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.
Klein G, Ernberg I. Human Herpesviruses. Future microbiology. Early events in Epstein-Barr virus infection of human B lymphocytes. Harada S, Kieff E. Cell growth effects of Epstein—Barr virus leader protein. Journal of general virology. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway.
Experimental cell research. Epstein-Barr virus nuclear antigen leader protein induces expression of thymus-and activation-regulated chemokine in B cells. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
International immunology. Epstein-Barr virus leader protein enhances EBNAmediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Molecular Pathology. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.
Journal of Virology. The Epstein-Barr virus latent membrane protein-1 LMP1 mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Xie P, Bishop GA. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.
The Journal of Immunology. Lam N, Sugden B. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. The EMBO journal. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future oncology.
The significance of LMP1 expression in nasopharyngeal carcinoma. In: Seminars in cancer biology. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma. Expert reviews in molecular medicine.
Hatzivassiliou E, Mosialos G. European journal of cancer Oxford, England: Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis.
Rovedo M, Longnecker R. Fruehling S, Longnecker R. An integral membrane protein LMP2 blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. PLoS pathogens. A comprehensive prescription for plant miRNA identification. Frontiers in plant science. Identification of virus-encoded microRNAs. Profiling of virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis.
Pathobiologic roles of epstein-barr virus-encoded microRNAs in human lymphomas. International journal of molecular sciences. Neoplasia New York, NY. Identification of novel genes that mediate innate immunity using inbred mice. Molecular medicine reports. Journal of Cancer. Gulley ML. The Journal of Molecular Diagnostics. BMJ open. Nasopharyngeal Epstein-Barr virus load: an efficient supplementary method for population-based nasopharyngeal carcinoma screening.
Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One. American journal of clinical pathology. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
BMC infectious diseases. Gulley ML, Tang W. Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.
Clin Microbiol Rev. Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Rochford R, Moormann AM. Burkitt's lymphoma. Epstein Barr Virus Volume 1: Springer. Magrath IT. African Burkitt's lymphoma. History, biology, clinical features, and treatment. God JM, Haque A. Burkitt lymphoma: pathogenesis and immune evasion.
Journal of oncology The link between Plasmodium falciparum malaria and endemic Burkitt's lymphoma—new insight into a year-old enigma. Bornkamm GW. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers. International journal of cancer. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
Frontiers in immunology. Adult Burkitt leukemia and lymphoma. Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.
Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Transplant immunology. Epstein-Barr virus infection and nasopharyngeal carcinoma. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.
Kirchmaier AL, Sugden B. Frappier L. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. New England Journal of Medicine. Molecular diagnosis of Burkitt's lymphoma. Structure and consequences of IGH switch breakpoints in Burkitt lymphoma.
Journal of the National Cancer Institute Monographs. Allday MJ. Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer epidemiology. Epidemiological overview of Hodgkin lymphoma across the mediterranean basin. Mediterranean journal of hematology and infectious diseases. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. EBV in Hodgkin lymphoma.
Epstein-Barr virus and the origin of Hodgkin lymphoma. Sub-category All. Year All The infection usually remains undetected throughout their life.
This is one of the most common types of cancer in young adults in these countries. So how does EBV cause completely different diseases in different parts of the world?
M81, as this particular type of virus is called, has certain peculiarities. In contrast, virus strains that cause glandular fever in Europe almost only infect B cells. Your donations help us do more We are an independent charity and are not backed by a large company or society. Thank you for your support. Advanced breast cancer patients denied opportunities to join clinical trials 4 Nov Therapy using dual immune system cells effectively controls neuroblastoma 23 Sep POT1 gene mutation predisposes to glioma and affects survival in a sex-specific manner 21 Apr Study leads to the identification of a new drug target for brain cancer 20 Apr
0コメント